Clinical Research Task

Context:
- It can (typically) involve Clinical Researchers.
- It can (typically) be associated with Clinical Research Concepts, instantiated in a clinical research terminology.
- It can (typically) be associated with Clinical Research Data.
- It can (often) involve a Clinical Study, such as a clinical intervention trial.
- It can be supported by a Clinical Research Supporting Organization.
- It can be the study area of a Clinical Research Discipline
- ...
Example(s):
- Clinical Study Design, such as: clinical trial design.
- Clinical Study Analysis.
- Clinical Study Reporting.
- ...
Counter-Example(s):
- Pre-Clinical Research.
- New Manufacturing System R&D.
- Clinical Practice, such as medical diagnosis.
See: Clinical Trial, Medical Treatment, Healthcare Science, Efficacy, Medications, Medical Device, Diagnostics.

References

(Wikipedia, 2021) ⇒ https://en.wikipedia.org/wiki/Clinical_research Retrieved:2021-11-3.
- Clinical research is a branch of healthcare science that determines the safety and effectiveness (efficacy) of medications, devices, diagnostic products and treatment regimens intended for human use. These may be used for prevention, treatment, diagnosis or for relieving symptoms of a disease. Clinical research is different from clinical practice. In clinical practice established treatments are used, while in clinical research evidence is collected to establish a treatment.

(Friesen et al., 2017) ⇒ Phoebe Friesen, Lisa Kearns, Barbara Redman, and Arthur L. Caplan. (2017). “Rethinking the Belmont Report?. ” The American Journal of Bioethics, 17(7).
- QUOTE: ... Defining research and practice as interventions aimed at knowledge and interventions aimed at well-being is incompatible with Belmont’s own principles of respecting persons, maximizing beneficence, and ensuring justice. The boundaries around what requires oversight should be defined pragmatically, so that knowledge production and benefits to all communities are maximized and harms to participants are minimized. Oversight should be required for any research or intervention involving novel, significant risks that are not part of the standard of care. This would encourage low-risk data collection during routine practice and ensure that innovative therapies are regulated and their findings disseminated. Investigators ought to be permitted to engage in low-risk or minimally risky research with minimal oversight, while regulatory mechanisms for experiments with significant risks should be kept in place. Regulation ought to be proportionate to novelty and level of risk, rather than derived from intent. ...